Markets › India › NSE › KREBSBIO

Krebs Biochemicals & Industries Ltd

NSE:KREBSBIOHealthcare

₹58.66+1.35%Delayed 15 minIn session · ≈ AED 2.27 · Market cap $13.17M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	−35.3%	−9.7%	46.8%	−21.6%	87.2%	27.5%	—	—
Operating margin	−61.3%	−66.1%	−42.1%	−30.7%	−50.1%	−50.0%	−50.0%	+0.0 pts
Net margin	−73.5%	−74.6%	−47.4%	−39.1%	−62.2%	−71.4%	−71.4%	+0.0 pts
EBITDA margin	−43.9%	−55.0%	−29.1%	−16.4%	−33.1%	−14.4%	—	—
Return on equity	66.4%	59.3%	24.8%	16.5%	18.4%	10.4%	10.4%	+0.0 pts
Return on assets	−17.8%	−23.5%	−14.1%	−11.1%	−15.9%	−10.4%	−10.4%	+0.0 pts
Return on capital employed	−21.3%	−35.3%	−17.4%	−13.3%	−33.2%	−23.7%	—	—
Debt / equity	−2.6×	−2.5×	−1.8×	−2.0×	−1.5×	−1.4×	−1.4×	+0.0%
Debt / assets	69.8%	99.1%	104.7%	134.0%	125.5%	137.7%	—	—
Interest coverage	−3.8×	−7.3×	−7.4×	−3.3×	−3.7×	−1.7×	—	—
Current ratio	0.4×	0.5×	0.3×	0.3×	0.1×	0.1×	0.1×	+0.0%
Quick ratio	0.1×	0.1×	0.1×	0.1×	0.0×	0.0×	—	—
Cash ratio	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Asset turnover	0.2×	0.3×	0.3×	0.3×	0.3×	0.1×	—	—
Inventory turnover	3.1×	2.5×	2.2×	6.0×	0.9×	3.0×	—	—
Receivables turnover	102.6×	54.9×	66.2×	10.7×	866.2×	5,519.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—